Clinical Trial Update: An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating the efficacy and safety of re-treatment with bortezomib in patients with multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED